Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer

Q2 Medicine

BMC Clinical Pathology Pub Date : 2015-11-18 DOI:10.1186/s12907-015-0020-6

R. Arsenić, D. Treue, A. Lehmann, M. Hummel, M. Dietel, C. Denkert, J. Budczies

引用次数: 62

查看原文本刊更多论文

靶向下一代测序与Sanger测序检测乳腺癌中PIK3CA突变的比较

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Clinical Pathology Medicine-Pathology and Forensic Medicine

CiteScore

3.30

自引率

0.00%

发文量

期刊介绍： BMC Clinical Pathology is an open access journal publishing original peer-reviewed research articles in all aspects of histopathology, haematology, clinical biochemistry, and medical microbiology (including virology, parasitology, and infection control). BMC Clinical Pathology (ISSN 1472-6890) is indexed/tracked/covered by PubMed, CAS, EMBASE, Scopus and Google Scholar.